Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2905 - 2912 of 12086 results
N.D. Ill. Finds that a Foreign Parent Corp. May be Sued Under BPCIA Without the U.S. Subsidiary that Signed and Filed aBLA
September 21, 2021| Blog| Viewpoint
OPT Class Action Settlement Will Help US Retain Talent
September 21, 2021| News
Monthly TCPA Digest — September 2021
September 21, 2021| Article| Viewpoint
TCPA Regulatory Update — FCC Attempts to Curb Robocalls to 911 Call Centers; Stop Illegal Robocalls from Entering American Phone Networks
September 21, 2021| Article| Viewpoint
TCPA Litigation Update — Sixth Circuit Holds TCPA Claims Arising Between November 2015 and July 2020 Are Viable
September 21, 2021| Article| Viewpoint
Levelling the Playing Field in ITC Patent Cases by Identifying Redesigns to a Set Deadline
September 21, 2021| News
When It Isn’t Better Late Than Never: ALJ Reins in on Redesigns First Disclosed in the Last Week of Fact Discovery
September 21, 2021| Blog| Viewpoint
USCIS Announces New COVID-19 Vaccination Requirement for Immigration Medical Examinations
September 20, 2021| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|